Analysts at StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a research note issued on Sunday. The firm set a “hold” rating on the stock.
TherapeuticsMD Trading Down 0.6 %
Shares of NASDAQ TXMD opened at $1.71 on Friday. TherapeuticsMD has a twelve month low of $1.43 and a twelve month high of $3.25. The business has a 50 day simple moving average of $1.76 and a 200-day simple moving average of $1.95.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last released its earnings results on Monday, August 12th. The company reported ($0.09) earnings per share for the quarter. The business had revenue of $0.23 million for the quarter.
Institutional Trading of TherapeuticsMD
TherapeuticsMD Company Profile
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Recommended Stories
- Five stocks we like better than TherapeuticsMD
- How to Choose Top Rated Stocks
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Business Services Stocks Investing
- MarketBeat Week in Review – 9/16 – 9/20
- Retail Stocks Investing, Explained
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.